Sisunatovir
Sisunatovir is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
Clinical Trials (6)
A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6